The assessment of immunogenicity biopharmaceuticals is a crucial step in the process their development. Immunogenicity related to activation adaptive immunity. complexity immune system manifests through numerous different mechanisms, which allows use approaches for predicting biopharmaceuticals. direct experimental are sometimes expensive and time consuming, or results need be confirmed. In thi...

Patents for the first generation of approved biopharmaceuticals have either expired or are about to expire. Thus the market is opening for generic versions, referred to as 'biosimilars' (European Union) or 'follow-on protein products' (United States). Healthcare professionals need to understand the critical issues surrounding the use of biosimilars to make informed treatment decisions.The compl...

UPT Parent Seeds of Ornamental Plants and Biopharmaceuticals North Sumatra Province acts as a plant pilot site, carries out testing/observation new varieties, purification regional superior varieties seeds, training human resources, especially apprenticeships for seed breeders, collection germplasm sources originating from regions areas in the province outside well abroad. Commodities ornamenta...

Plants are now gaining widespread acceptance as a general platform for the large-scale production of recombinant proteins. The first plant-derived recombinant pharmaceutical proteins are reaching the final stages of clinical evaluation, and many more are in the development pipeline. Over the past two years, there have been some notable technological advances in this flourishing area of applied ...